Skip to main content

Table 1 Pharmacokinetic properties of some anti-arrhythmic and antithrombotic drugs commonly used in management of cardiac arrhythmia

From: Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope

 

Major route of elimination

Involved cytochrome P450 enzymes

Protein binding %

Transporters

References

Anti-arrhythmic Drugs

Class Ia

Quinidine

Hepatic and renal

CYP3A4, CYP2D6

80

P-glycoprotein, OCT2, OCT3

[47, 52, 53]

Disopyramide

Renal

CYP3A4

50–65

OCT2, OCT3

[53]

Procainamide

Hepatic and renal

CYP2D6

20

MATE; OCT3

[53,54,55]

Class Ib

Lidocaine

Hepatic

CYP1A2, CYP3A4

60–80

OCT3

[53, 55, 56]

Phenytoin

Hepatic

CYP2C19; CYP2C9

90

OCT3

[53, 57]

Mexiletine

Hepatic

CYP2D6

70

OCT2, OCT3

[53, 58, 59]

Tocainide

Hepatic and renal

CYP3A4

50

 

[60]

Class Ic

Flecainide

Hepatic and renal

CYP2D6

20

OCT2

[59, 61]

Propafenone

Hepatic

CYO2D6, CYP3A4

90

OCT2

[59, 62]

Class II

Esmolol

Blood esterase

…….

55

 

[63]

Metoprolol

Hepatic

CYP2D6

  

[64]

Class III

Amiodarone

Hepatic

CYP1A2, CYP2C9, CYP2D6

96

P-glycoprotein, OAT2B1

[47, 65]

Sotalol

Renal

CYP3A4

0

OCT2

[47, 65, 66]

Ibutilide

Hepatic and renal

undetermined

…

 

[67]

Dofetilide

Hepatic and renal

CYP3A4

60–70

MATE: OCT2

[55, 68]

Class IV

Verapamil

Hepatic

CYP3AF, CYP3A5

90

P-glycoprotein, OCT2

[47, 52]

Diltiazem

Hepatic

CYP3AF, CYP3A5

70–80

P-glycoprotein

[47, 52]

Others

Adenosine

Cellular metabolism

……

……

 

[69]

Digoxin

Renal

……

20–30

P-glycoprotein

[47, 70]

Antithrombotic

Warfarin

Hepatic

CYP1A2, CYP2C19, CYP3A4

99

 

[71]

Aspirin*

Hepatic

CYP2D9

58.3–81.7#

OAT1

[72,73,74]

Dabigatran

Renal

CYP3A4

35

P-glycoprotein

[70, 75]

Edoxaban

Renal

….

40–59

P-glycoprotein

[70, 76]

Rivaroxaban

Hepatic and renal

CYP3A4, CYP3A5, CYP2J2

92–95

P-glycoprotein

[70, 77]

Apixaban

Hepatic and renal

CYP3A4, CYP1A2, 2C8, 2C9, 2C19

93

P-glycoprotein

[47, 70, 78]

  1. *Other Aspirin metabolizing enzymes: N-acetyl transferase2(NAT2) an UDP-glucuronosyltransferase 1A6(UGT1A6). # The plasma protein binding of aspirin ranges from approximately 58.3 for aspirin and 81.7 for salicylates. MATE multi-drug and toxin extrusion proteins, OAT organic anion transporter, OCT organic cation transporter